Relapsed Ovarian Cancer Patients with Ascites and/or Pleural Effusion Still Benefit from Treatment: A Real-Life Study

Relapsed Ovarian Cancer Patients with Ascites and/or Pleural Effusion Still Benefit from Treatment: A Real-Life Study

(1) Background: Relapsed HGSOC with ascites and/or pleural effusion is a poor-prognostic population and poorly represented in clinical studies. We questioned if these patients are worth treating. In other words, if these patients received the most effective treatment, would it change the course of t...

Full description

Bibliographic Details
Main Authors: Mariana Rebordão-Pires, Marta F. Estrada, António Gomes, Filipa Silva, Carlota Baptista, Maria João Ramos, Ana Fortuna, Pedro Simões, Gabriela Sousa, Ana Marreiros, Rita Fior
Format: Article
Language:English
Published: MDPI AG 2023-12-01
Series:Cancers
Subjects:
relapsed ovarian cancer
ascites
pleural effusion
overall survival
Online Access:https://www.mdpi.com/2072-6694/16/1/162

Similar Items

Similar Items